Investing

Carl Icahn Goes After Biogen Idec (BIIB)

Biogen_logoBiogen Idec (NASDAQ: BIIB) is coming under fire from activist investor Carl Icahn this morning.  A release came out as a "shareholder proposal" from Icahn Partners LP.  He is asking for four positions for new board members, as well as jurisdiction changes.

Icahn and certain affiliates are proposing the nomination of fourindividuals to serve on the board of directors of the company at theannual meeting:

  • Alexander J. Denner,
  • Richard C. Mulligan,
  • Thomas J. Deuel,
  • and David Sidransky

The proposal also seeks to request that the board changes its companyjurisdiction of incorporation to North Dakota and to amend the bylawsto set the size of the Board at 13.

Biogen Idec’s Board will review the notice and consider it in light ofthe best interests of all shareholders of the Company….

Jon C. Ogg
February 6, 2009

Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE

Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here
you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.


Click here
to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.